Fundraising Fox
Microbiotica
Cambridge, GB · Founded 2016 · 53 employees on LinkedIn · 4 known investors
Find your way into Microbiotica
Sign up to see every warm intro you have to Microbiotica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Microbiotica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.
Founders & leadership
Microbiotica was founded in 2016 by Trevor Lawley.
Investors · 4
How we know: a partner's Signal profile · the Companies House PSC register · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Seventure Partners's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Related companies · 2
Companies working in the same space as Microbiotica.
Companies House · registry record
View on Companies House ↗- Registered name
- MICROBIOTICA LIMITED
- Company number
- 10269808
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 8 Jul 2016
- Registered office
- Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2025 · next due 30 Sept 2027
- Confirmation statement
- last made up to 7 Jul 2026 · next due 21 Jul 2027
Current officers · 7
- Carmine Daniel Circelli — director, appointed 12 Jan 2023
- Viet-Anh Anne Horgan — director, appointed 1 May 2025
- Trevor David Lawley — director, appointed 8 Jul 2016
- Mark Royston Quick — director, appointed 4 Mar 2022
- Johannes Gerardus Christiaan Petrus Schikan — director, appointed 1 Feb 2021
- Timothy Sharpington — director, appointed 1 Jan 2023
- Ip2ipo Services Limited — corporate director, appointed 15 Dec 2016
Source: Companies House public register · retrieved 7 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does Microbiotica do?
- Microbiotica is a clinical-stage biopharmaceutical company developing precision live biotherapeutic products derived from the human microbiome for immuno-oncology and inflammatory bowel disease. The company uses a proprietary microbiome profiling platform based on clinical data to identify specific bacterial strains associated with patient benefit.
- Who founded Microbiotica?
- Microbiotica was founded by Trevor Lawley in 2016.
- Who are Microbiotica's investors?
- Microbiotica's investors include Cambridge Innovation Capital, Seventure Partners, DCVC (Data Collective), IP Group.
- Where is Microbiotica headquartered?
- Microbiotica is headquartered in Cambridge, GB.